Drdgold (DRDGF)


DRDGOLD Limited is a South African gold mining company listed on OTC Markets as common stock. The company focuses on recovering gold from the retreatment of surface mine tailings in South Africa and also sells gold and silver bullion. In addition to its core mining activities, DRDGOLD provides care and maintenance services, generates renewable power, offers employee home loans, and operates a training center. Formerly known as Durban Roodepoort Deep Limited, the company adopted the DRDGOLD name in 2004. Incorporated in 1895 and headquartered in Johannesburg, South Africa, it operates as a subsidiary of Sibanye Gold Limited.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-DRDG.F
$2.62
24.1% Upside
Undervalued
Excellent
0.05
2.6%
August 19, 2026
8.8x
2.6x
3.1x
1.704 B
1.559 B
0.0%
49.8%
8.9
18.9%
49.3%
Valuation • Fair Value

Drdgold (OTC-DRDG.F) Fair Value by Valuation Model

Compare the primary fair value estimate for Drdgold (OTC-DRDG.F) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$2.62

Estimated upside of 24.1% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$3.24

Discounted cash flow valuation reference.

Ben Graham Formula Value

$2.54

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$1.38

Earnings power value estimate.

Comps Fair Value

$2.20

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Drdgold (OTC-DRDG.F) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Drdgold (OTC-DRDG.F)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

551.3 M

Current operating scale indicator.

Revenue Forecast

647.8 M

Forward revenue estimate.

EBITDA

271.3 M

Current operating profitability reference.

EBITDA Forecast

364.3 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Drdgold (OTC-DRDG.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Drdgold (OTC-DRDG.F)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Excellent

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.96

No elevated caution signal from this screen.

Altman Z-Score

8.9

Relatively strong balance-sheet zone.

FCF / Net Income

49.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Drdgold (OTC-DRDG.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Drdgold (OTC-DRDG.F)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 19, 2026

Days to Earnings

29

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

2.6%

Income yield reference.

Upcoming Dividend

0.05

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

ZAR

Currency used for the distribution.

Payout Ratio

18.9%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Drdgold (OTC-DRDG.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Drdgold (OTC-DRDG.F) Stock Forecast & Technical Outlook

Review Drdgold (OTC-DRDG.F) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Drdgold (OTC-DRDG.F) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for Drdgold (OTC-DRDG.F) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Drdgold (OTC-DRDG.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Drdgold (OTC-DRDG.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Drdgold (OTC-DRDG.F) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Drdgold (OTC-DRDG.F)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Drdgold (OTC-DRDG.F) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ Fast Investor Answers

Drdgold (OTC-DRDG.F) Stock FAQ

Quick answers about Drdgold (OTC-DRDG.F) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$2.62
Estimated upside 24.1%
Valuation Rating
Undervalued
Estimated upside of 24.1%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Excellent
Current financial-health read

The current fair value estimate for Drdgold (OTC-DRDG.F) is $2.62. This implies an estimated upside of 24.1% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 24.1% versus the current market price.

An analyst price target for Drdgold (OTC-DRDG.F) is not currently available in the latest data file.

The current financial health read for Drdgold (OTC-DRDG.F) is Excellent. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Drdgold (OTC-DRDG.F) is August 19, 2026.

Based on the current data, dividend yield is 2.6%, upcoming dividend amount is 0.05.

The current P/E ratio listed for Drdgold (OTC-DRDG.F) is 8.8x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Drdgold is 1.704 B.

The current enterprise value listed for Drdgold is 1.559 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Drdgold is OTC-DRDG.F, and the stock is listed on OTC Markets.

Drdgold (OTC-DRDG.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Drdgold is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Drdgold is 49.8%. Free float helps investors understand how much of the share base is available for public trading.